![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Immune Therapeutics Inc (PK) | USOTC:IMUN | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.093 | 0.072 | 0.10 | 0.00 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
||||
(State or Other Jurisdiction | (Commission | (I.R.S. Employer | ||
of Incorporation) | File Number) | Identification No.) |
(Address of Principal Executive Offices) (Zip Code)
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
OTC PINK |
SECTION 5 — CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. | |
Appointment of Roger Craig Suro as Director | ||
On November 8, 2023 the board of directors of Biostax Corp, (the “Company”) appointed Mr. Roger Craig Suro, age 49 to the Board of Directors in accordance with the bylaws of the Issuer. | ||
Mr. Suro began his career in the public section where he was Virginia’s Assistant Secretary of Health and Human Resources under Secretary Jane Woods. He later became a real estate developer with Realty Venture Groups LLC and has been a partner at Varidian LLC, a chemical manufacturer since 2009. In 2010 he co-founded CareTime LLC, a software company that supports home care agencies and he currently remains a principal there. In 2014 he co-founded the Tangier Island Oyster Company, a not for profit advocacy organization. From 2020-2022 he worked as a consultant at Statera Biopharma where he analyzed national legislation and policy proposals and advised the company on their potential impacts. | ||
Since 2016 he has been on the HCA Hospitals of Richmond board and the HCA Division Region Market Advisory Committee. He has also been on the Pharma Doctors Hospital Board since 2022, the Greater Richmond YMCA board since 2013 and volunteers on its Property and Facilities committee. He has also been on the Steward School Board of Trustees since 2023 and the Community Board for the Blue Ridge Bank since 2018. | ||
In 1997 he graduated from Clemson University with a Bachelor of Science degree in Business Commerce and he received an Executive Mini MBA from the University of Richmond in 2016. | ||
There are no arrangements or understandings between Mr. Suro and any other persons pursuant to which he was selected as a director. There are no family relationships that exist between Mr. Suro and any directors or executive officers of the Company. In addition, there has been no transaction, nor is there any currently proposed transaction between Mr. Suro and the Company that would require disclosure under Item 404(a) of Regulation S-K. |
SECTION 8 — OTHER EVENTS
Item 8.01 | Other Events. | |
On November 15, 2023 Biostax Corp (the “Company”) issued a press release announcing the appointment of Mr. Roger Craig Suro to the Board of Directors. A Copy of the press release is attached to this report as Exhibit 99.1. The press release furnished in this report as Exhibit 99.1 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. |
SECTION 9 — FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01 | Financial Statements and Exhibits. | |
(d) Exhibits. |
Exhibit No. | Description of Exhibit | |
99.1 | Press Release Dated November 15, 2023 | |
104 | Cover Page Interactive Data File (Embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
BISOSTAX CORP | ||
By | /s/ Noreen Griffin | |
Name: Noreen Griffin Title: Chief Executive Officer |
Date: November 15, 2023
INDEX TO EXHIBITS
Exhibit No. | Description | |
99.1 | Press Release Dated November 15, 2023 | |
104 | Cover Page Interactive Data File (Embedded within the Inline XBRL document) |
Exhibit 99.1
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro
Orlando, FL, November 15, 2023 (GLOBE NEWSWIRE) — Biostax Corp (OTC Pink: BTAX) (“Biostax”), a hub and spoke biotech development engine, announces the appointment of Influential Business Leader Roger “Craig” Suro.
Renowned Virginia native, Mr. Suro, has emerged as a driving force in the realms of business innovation, public policy, and community revitalization. With an extensive background in business development and public service, Mr. Suro has continually spearheaded transformative initiatives that have left a lasting impact on Virginia’s economic landscape.
In welcoming Mr. Suro, the Company’s CEO, Noreen Griffin, remarked, “We are thrilled to have Craig join our team. His remarkable track record in driving capital, innovation, and funding for transformative projects is unparalleled. His expertise will undoubtedly amplify our company’s growth trajectory. With Craig on board, we anticipate a surge in innovation, unparalleled opportunities for our company, and increased funding avenues that will propel us to new heights of success.”
Mr. Suro’s journey began Virginia’s Assistant Secretary of Health and Human Resources under the office of Secretary Jane Woods where he exhibited exceptional leadership in policy coordination, legislative affairs, and relationship building with state healthcare agencies. His expertise in healthcare policies laid the foundation for his venture into the private sector, where he co-founded Caretime LLC in 2010. This private healthcare software company, under Mr. Suro’s guidance, achieved remarkable success, experiencing an average annual revenue growth of 52%. Caretime’s innovative solutions empowered healthcare providers across 26 states in detecting fraud within Medicaid- and Medicare-funded home healthcare services.
Recognized for his entrepreneurial acumen, Mr. Suro ventured into the aquaculture industry in 2014, founding the not-for profit,Tangier Island Oyster Company. His vision revitalized the economy of Tangier Island, providing over 1 million premium brand oysters annually to select restaurants creating a range of new employment opportunities and establishing a sustainable market for premium oysters.
In recent years, Mr. Suro’s focus has shifted towards the burgeoning field of Biotechnology. Collaborating with leading companies in the Richmond/Petersburg region, he has been instrumental in driving innovative drug research and manufacturing projects. His consultancy work ensures that these initiatives maximize growth, fostering synergies that benefit communities, national safety, and public health.
Mr. Suro’s dedication to community development is reflected in his service on several boards and committees. He serves on the Greater Richmond YMCA Board and currently volunteers on the Property and Facilities committee. Presently, he serves on the HCA Central Division Region Market Advisory Committee, the Community Board for Blue Ridge Bank, and the Board of Trustees for The Steward School.
With a legacy marked by innovation, collaboration, and community empowerment, Craig Suro continues to shape Virginia’s future. His dynamic approach and visionary leadership make him a driving force behind transformative change, leaving an indelible mark on businesses, communities, and industries alike.
Cover |
Nov. 08, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Nov. 08, 2023 |
Entity File Number | 000-54933 |
Entity Registrant Name | BIOSTAX CORP |
Entity Central Index Key | 0001559356 |
Entity Tax Identification Number | 59-3226705 |
Entity Incorporation, State or Country Code | FL |
Entity Address, Address Line One | 2431 Aloma Ave |
Entity Address, Address Line Two | Suite 124 |
Entity Address, City or Town | Winter Park |
Entity Address, State or Province | FL |
Entity Address, Postal Zip Code | 32792 |
City Area Code | 888 |
Local Phone Number | 391-9355 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common |
Trading Symbol | BSTAX |
1 Year Immune Therapeutics (PK) Chart |
1 Month Immune Therapeutics (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions